GenomeUp is a precision medical Saas, it allows doctors to fully exploit the potential of Artficial Intelligence (AI).
Doctors get a detailed clinical report on genes affecting patients’ pathologies, the gravity of the new selected mutations and the last personalized therapies, mining the information from the world’s biggest biomedical database PubMed, on the basis of patients’ genetic data.
Integrating the genome knowledge and the translational medicine GenomeUp aims to improve patients’ treatments through the latest computer technologies.
Doctors get a detailed clinical report on genes affecting patients’ pathologies, the gravity of the new selected mutations and the last personalized therapies, mining the information from the world’s biggest biomedical database PubMed, on the basis of patients’ genetic data.
Integrating the genome knowledge and the translational medicine GenomeUp aims to improve patients’ treatments through the latest computer technologies.
Location: Italy, Lazio, Rome
Employees: 11-50
Phone: +39 339 844 8838
Total raised: $231.18K
Founded date: 2017
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.08.2018 | - | $231.18K | - |
Mentions in press and media 6
| Date | Title | Description |
| 08.09.2026 | Techshop II chiude a 43 milioni e punta sull’AI B2B | Techshop SGR ha completato il primo closing di Techshop II, il nuovo fondo di venture capital dedicato alle startup pre-seed e seed che sviluppano soluzioni B2B basate sull’intelligenza artificiale. La raccolta ha raggiunto 43 milioni di eu... |
| 08.02.2022 | Italy’s AI-powered rare genetic disease detector GenomeUp raises $1.2 million | Rome-based medical SaaS GenomeUp is using Artificial Intelligence to power a series of solutions for genetic analysis and clinical decision support for diseases, and has raised $1.2 million in a seed funding round. The investment will be us... |
| 06.08.2018 | AI Driven Biomedicine Startup GenomeUp Raises €200K | GenomeUp, a Rome, Italy-based AI driven biomedicine company, raised €200k in funding. Backers included LVenture Group (LVEN.MI) and business angels from the Angel Partner Group. The company will use the funds to continue development efforts... |
| - | Italy’s AI-powered rare genetic disease detector GenomeUp raises $1.2 million | Rome-based medical SaaS GenomeUp is using Artificial Intelligence to power a series of solutions for genetic analysis and clinical decision support for diseases, and has raised $1.2 million in a seed funding round. The investment will be us... |
| - | GenomeUp | “We support doctors in drawing the diagnosis and therapy with our Artificial Intelligence On the basis of patients’ genetic data, GenomeUP allows doctors to get a detailed clinical report on genes affecting patients’ pathology and their per... |
| - | GenomeUp | “GenomeUp” |